Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01610206
Title A Randomized Study of Safety and Efficacy of Pazopanib and Gemcitabine in Persistent or Relapsed Ovarian Cancer
Recruitment Completed
Gender female
Phase Phase II
Variant Requirements No
Sponsors Linda R Duska
Indications

peritoneum cancer

fallopian tube cancer

ovarian cancer

Therapies

Gemcitabine + Pazopanib

Gemcitabine

Age Groups: adult
Covered Countries USA


No variant requirements are available.